Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3903 ARTÍCULOS , VIENDO DEL 571 AL 585

Self-rated health in multimorbid older general practice patients: a cross-sectional study in Germany

Nützel A, Dahlhaus A, Fuchs A, Gensichen J, König HH, Riedel-Heller S, Maier W, Schäfer I, Schön G, Weyerer S, Wiese B, Scherer M, van den Bussche H, Bickel H.

BMC Fam Pract. 2014 Jan 3;15:1. doi: 10.1186/1471-2296-15-1.

Management of neurogenic orthostatic hypotension

Arbique D, Cheek D, Welliver M, Vongpatanasin W.

J Am Med Dir Assoc. 2014 Apr;15(4):234-9. doi: 10.1016/j.jamda.2013.10.014. Epub 2014 Jan 2.

The effect of natural and synthetic fatty acids on membrane structure, microdomain organization, cellular functions and human health

Ibarguren M, López DJ, Escribá PV.

Biochim Biophys Acta. 2014 Jun;1838(6):1518-28. doi: 10.1016/j.bbamem.2013.12.021. Epub 2014 Jan 3.

Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?

Bisaglia M, Filograna R, Beltramini M, Bubacco L.

Ageing Res Rev. 2014 Jan;13:107-14. doi: 10.1016/j.arr.2013.12.009. Epub 2014 Jan 3.

Disruption of the blood-brain barrier in Parkinson's disease: curse or route to a cure?

Lee H, Pienaar IS.

Front Biosci (Landmark Ed). 2014 Jan 1;19(2):272-80. doi: 10.2741/4206.

Parkinson's disease: a review

Beitz JM.

Front Biosci (Schol Ed). 2014 Jan 1;6(1):65-74. doi: 10.2741/s415.

Significance of metallothioneins in aging brain

Sharma S, Ebadi M.

Neurochem Int. 2014 Jan;65:40-8. doi: 10.1016/j.neuint.2013.12.009. Epub 2014 Jan 3.

Preconditioning provides neuroprotection in models of CNS disease: paradigms and clinical significance

Stetler RA, Leak RK, Gan Y, Li P, Zhang F, Hu X, Jing Z, Chen J, Zigmond MJ, Gao Y.

Prog Neurobiol. 2014 Mar;114:58-83. doi: 10.1016/j.pneurobio.2013.11.005. Epub 2014 Jan 2.

Conceptualizing and prioritizing clinical trial outcomes from the perspectives of people with Parkinson's disease versus health care professionals: a concept mapping study

Sjödahl Hammarlund C, Nilsson MH, Idvall M, Rosas SR, Hagell P.

Qual Life Res. 2014 Aug;23(6):1687-700. doi: 10.1007/s11136-013-0614-3. Epub 2014 Jan 4.

Association between PITX3 promoter polymorphism and risk of Parkinson's disease: the impact of ethnicity and onset age

Qiu G, Fu C, Liang GH.

Neurosci Lett. 2014 Feb 21;561:128-33. doi: 10.1016/j.neulet.2013.12.054. Epub 2014 Jan 3.

Phagocytosis of microglia in the central nervous system diseases

Fu R, Shen Q, Xu P, Luo JJ, Tang Y.

Mol Neurobiol. 2014 Jun;49(3):1422-34. doi: 10.1007/s12035-013-8620-6. Epub 2014 Jan 7.

Chlorpromazine versus placebo for schizophrenia

Adams CE, Awad GA, Rathbone J, Thornley B, Soares-Weiser K.

Cochrane Database Syst Rev. 2014 Jan 6;2014(1):CD000284. doi: 10.1002/14651858.CD000284.pub3.

Interleukin-10-1082A/G and -592C/A polymorphisms with risk of Parkinson's disease: a meta-analysis

Jin J, Wu P, Li W, Shi J, Chen J, Li R, Tan S.

Int J Neurosci. 2014 Nov;124(11):852-8. doi: 10.3109/00207454.2014.880910. Epub 2014 Feb 7.

Definite familial multiple system atrophy with unknown genetics

Itoh K, Kasai T, Tsuji Y, Saito K, Mizuta I, Harada Y, Sudoh S, Mizuno T, Nakagawa M, Fushiki S.

Neuropathology. 2014 Jun;34(3):309-13. doi: 10.1111/neup.12092. Epub 2014 Jan 7.

Italian version of the Parkinson Neuropsychometric Dementia Assessment (PANDA): a useful instrument to detect cognitive impairments in Parkinson's Disease

Pignatti R, Bertella L, Scarpina F, Mauro A, Portolani E, Calabrese P.

J Parkinsons Dis. 2014;4(2):151-60. doi: 10.3233/JPD-130270.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias